GammaDelta Therapeutics initiates first-in-human Phase 1 trial of GDX012 for the treatment of acute myeloid leukemia
First dose delivered to patients in a multi-center U.S. clinical trial to evaluate novel gamma-delta T cell cancer therapy
First dose delivered to patients in a multi-center U.S. clinical trial to evaluate novel gamma-delta T cell cancer therapy
For the second year running, Indica Labs has been named a top workplace by the Albuquerque Journal
Indica Labs is pleased to announce the formal launch of its software within the National Cancer Institute (NCI)
Multi-enzyme analysis can now be achieved through a single, fully automated enzyme analyzer
Watch this on-demand webinar to find out how you can streamline residual solvent analysis according to USP
Validating an expanded list of PFAS compounds from C4-C18 chain length
Skoltech researchers have synthesized a new conjugated polymer for organic electronics using two different chemical reactions
AMSBIO launches next generation cryopreservation media solution for cell therapy